Zura Bio Ltd. (ZURA)
4.04
-0.12
(-2.88%)
USD |
NASDAQ |
Sep 25, 16:00
4.045
0.00 (0.00%)
After-Hours: 19:59
Zura Bio Max Drawdown (5Y) : 97.00% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 97.00% |
| July 31, 2026 | 97.00% |
| June 30, 2026 | 97.00% |
| May 31, 2026 | 97.00% |
| April 30, 2026 | 97.00% |
| March 31, 2026 | 97.00% |
| Date | Value |
|---|---|
| February 28, 2026 | 97.00% |
| January 31, 2026 | 97.00% |
| December 31, 2025 | 97.00% |
| November 30, 2025 | 97.00% |
| October 31, 2025 | 97.00% |
| September 30, 2025 | 97.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| NovelStem International Corp. | 98.06% |
| Brainstorm Cell Therapeutics, Inc. | 46.35% |
| Summit Therapeutics, Inc. | 95.40% |
| Kezar Life Sciences, Inc. | 98.04% |
| Protara Therapeutics, Inc. | 99.25% |